Episode 13: Understanding Atrial Fibrillation: Pioneering Discoveries with Dr. Robert Rose

In this episode, host Ann-Marie delves into the complexities of Atrial Fibrillation (AF) with Dr. Robert Rose, a scientist and professor in the departments of Cardiac Sciences, Physiology and Pharmacology at the Cumming School of Medicine,⁠ Libin Cardiovascular Institute⁠ at the University of Calgary.

Unpacking the intricacies of cardiovascular disease, the⁠ Robert Rose Laboratory⁠ conducts cutting-edge research, and among many areas of focus, seeks to unravel the elusive causes of AF, a widespread cardiac condition that remains not fully understood. This discussion illuminates the promising role of the natriuretic peptide receptor B (NPR-B), a receptor in the heart, in regulating and sustaining normal heart rhythm. Impaired activity of the NPR-B is associated with a greater risk of developing AF. These findings could lead to the creation of new preventative treatments for AF in the form of NPR-B agonists.

Dr. Rose shares his enthusiasm for the innovative advancements in cardiac research and his hopeful perspective on future therapeutic strategies to prevent and manage arrhythmias and design patient-specific or condition-specific treatment approaches.

Click⁠ here⁠ to read the full study discussed in the episode.

For more information on the NPR-B research coming out of the Robert Rose Laboratory,⁠ click here⁠.